Published on
Monday, August 6, 2012
Burrill & Co. is already nearing an exit on one of a dozen
investments made from a new $505 million fund that had a second close last
week.
G. Steven Burrill told
BioCentury the undisclosed company already has "several term sheets and is
working on an exit." He expects an acquisition will come roughly a year
after the initial investment.